好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

TCD and EEG Combined Better Predicts DCI After SAH
Neuro Trauma, Critical Care, and Sports Neurology
S61 - Neurocritical Care: Cerebrovascular Disease (1:36 PM-1:48 PM)
004

To determine whether combining electroencephalography (EEG) with transcranial doppler (TCD) thresholds of vasospasm improves prediction of delayed cerebral ischemia (DCI) after subarachnoid hemorrhages (SAH).

DCI is a devastating complication of SAH. TCD remains the standard to monitor vasospasm, but is limited. EEG also predicts increased DCI risk (Vespa 1997; Kim 2017) and may surpass TCD (Rosenthal 2018). We hypothesize that EEG and TCD combined improves DCI prediction.

We retrospectively assessed 108 patients with moderate to severe SAH (2011-2015) with TCD and EEG. Middle cerebral artery (MCA) peak systolic velocity (PSV) and the presence of abnormal EEG patterns, (ictal-interictal continuum abnormalities; IICAs) were recorded daily. TCD velocities and their rates of increase between DCI and controls were compared (Wilcoxon Rank-Sum and slopes of linear mixed-effects models). The time relationship between TCD, IICAs, and DCI was visualized using cumulative probability curves. Multivariate logistic regression was used to identify significant TCD and IICA predictors of DCI.

MCA TCD median PSV were significantly higher in DCI vs controls on day of DCI (Wilcoxon Rank-Sum, p=0.03). Linear mixed effects modeling of TCD slopes from -4 to 0 days before DCI are significantly different (p<0.01). We found that IICAs, especially epileptiform discharges (ED) often precede high MCA velocities (PSV>200cm/sec) and DCI based on cumulative probability curves. High MCA PSV (p<0.01) and some IICA subtypes (+ED, +GPD, -GRDA) increase odds of DCI based on logistic regression (p<0.01). This regression model predicts DCI with an accuracy of 70% with an AUC of 0.738 (95% CI: 0.703–0.774) and improves upon accuracy of MCA or IICA presence alone (47% and 56%).

Our data suggest that combining both TCD values and IICA presence improves DCI prediction.

Authors/Disclosures
Hsin Yi Chen
PRESENTER
Miss Chen has nothing to disclose.
No disclosure on file
Eric Rosenthal, MD (Massachusetts General Hospital) Dr. Rosenthal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma, Inc. . Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell, Inc. . The institution of Dr. Rosenthal has received research support from Sage Therapeutics. Dr. Rosenthal has received intellectual property interests from a discovery or technology relating to health care.
Sahar Zafar, MD Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Zafar has received research support from NIH. Dr. Zafar has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker for a lecture with Marinus.
M. B. Westover, MD, PhD (MGH) Dr. Westover has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Jennifer A. Kim, MD (Yale University School of Medicine) Dr. Kim has nothing to disclose.